Andrew Symes

机构：National Health Service, University of Calgary, Royal Free London NHS Foundation Trust, The Royal Free Hospital, University College London · ORCID：0000-0003-2223-7909

发表论文 6 篇 · 总被引 94 次 · h-index 3

代表论文

Activation of the cGAS-STING innate immune response in cells with deficient mitochondrial topoisomerase TOP1MT (2023 · Human Molecular Genetics · 被引 36)
Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein (2023 · Clinical Infectious Diseases · 被引 34)
Functional characterization of two variants of mitochondrial topoisomerase TOP1MT that impact regulation of the mitochondrial genome (2022 · Journal of Biological Chemistry · 被引 20)
Activation of the cGAS-STING innate immune response in cells with deficient mitochondrial topoisomerase TOP1MT (2022 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 3)
Immunoglobulin Replacement Therapy During COVID-19 Pandemic: Practical and Psychological Impact in Patients with Antibody Deficiency (2023 · Journal of Clinical Immunology · 被引 1)
Functional characterization of two variants in the mitochondrial topoisomerase gene TOP1MT that impact regulation of the mitochondrial genome (2021 · bioRxiv (Cold Spring Harbor Laboratory))